Latest filing published 16 Nov 2021 for SAB Biotherapeutics, Inc., €22k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Russell P. Beyer: trading record in brief
This profile gathers the share dealings of Russell P. Beyer in SAB Biotherapeutics, Inc., where the filings describe the role as finance chief. Over a trading history stretching from 28 September 2021 to 26 October 2021, the count stands at 6 filings.
Every open-market trade on record is a sale: 1 sale worth €1,894. The rest of the record consists of 5 share grants.
The latest filing, published on 16 November 2021, reports a share grant of €1,285 in SAB Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 39 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Russell P. Beyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,475 shares@ US$10.10100.0% of flowCommon StockSEC:0001493152-21-028917:0
1 of 1 declaration